BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26646278)

  • 1. A Common CCK-B Receptor Intronic Variant in Pancreatic Adenocarcinoma in a Hungarian Cohort.
    Balázs A; Németh BC; Ördög B; Hegyi E; Hritz I; Czakó L; Czimmer J; Gódi S; Csiszkó A; Rakonczay Z; Párniczky A; Izbéki F; Halász A; Kahán Z; Hegyi P; Sahin-Tóth M;
    Pancreas; 2016 Apr; 45(4):541-5. PubMed ID: 26646278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival.
    Smith JP; Whitcomb DC; Matters GL; Brand RE; Liao J; Huang YJ; Frazier ML
    Pancreas; 2015 Mar; 44(2):236-42. PubMed ID: 25469546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.
    Smith JP; Harms JF; Matters GL; McGovern CO; Ruggiero FM; Liao J; Fino KK; Ortega EE; Gilius EL; Phillips JA
    Cancer Biol Ther; 2012 Feb; 13(3):164-74. PubMed ID: 22277584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous expression of cholecystokinin and gastrin receptor in stomach and pancreatic cancer: An immunohistochemical study.
    Rai R; Kim JJ; Tewari M; Shukla HS
    J Cancer Res Ther; 2016; 12(1):411-6. PubMed ID: 27072272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3'-splicing site leading to retention of the fourth intron.
    Ding WQ; Kuntz SM; Miller LJ
    Cancer Res; 2002 Feb; 62(3):947-52. PubMed ID: 11830556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
    Mjønes P; Nordrum IS; Sørdal Ø; Sagatun L; Fossmark R; Sandvik A; Waldum HL
    Horm Cancer; 2018 Feb; 9(1):40-54. PubMed ID: 28980157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCK(2) receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours.
    Körner M; Waser B; Reubi JC; Miller LJ
    J Cell Mol Med; 2010 Apr; 14(4):933-43. PubMed ID: 19627395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
    Wang OH; Azizian N; Guo M; Capello M; Deng D; Zang F; Fry J; Katz MH; Fleming JB; Lee JE; Wolff RA; Hanash S; Wang H; Maitra A
    PLoS One; 2016; 11(3):e0152300. PubMed ID: 27023625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of epoxide hydrolase Y113H gene variant in pancreatic diseases.
    Ockenga J; Strunck S; Post C; Schulz HU; Halangk J; Pfützer RH; Löhr M; Oettle H; Kage A; Rosendahl J; Keim V; Drenth JP; Jansen JB; Lochs H; Witt H
    Pancreas; 2009 May; 38(4):e97-e101. PubMed ID: 19287329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
    Cho JH; Bang S; Park SW; Chung JB; Song SY
    Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro.
    Huang H; Ansorge N; Schrader H; Banasch M; Yu HG; Schmidt WE; Höcker M; Schmitz F
    Regul Pept; 2007 Dec; 144(1-3):34-42. PubMed ID: 17936921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of genetic predisposition on the risk of gallbladder cancer in Hungary.
    Kimura A; Tsuchiya Y; Lang I; Zoltan S; Nakadaira H; Ajioka Y; Kiyohara C; Oyama M; Nakamura K
    Asian Pac J Cancer Prev; 2008; 9(3):391-6. PubMed ID: 18990008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 promoter polymorphism and pancreatic cancer risk and prognosis.
    Asomaning K; Reid AE; Zhou W; Heist RS; Zhai R; Su L; Kwak EL; Blaszkowsky L; Zhu AX; Ryan DP; Christiani DC; Liu G
    Clin Cancer Res; 2008 Jun; 14(12):4010-5. PubMed ID: 18559624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.
    Tiwari AK; Rodgers JB; Sicard M; Zai CC; Likhodi O; Freeman N; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1484-90. PubMed ID: 20732371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.
    Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Vickers SM; Buchsbaum DJ; Heslin MJ; Arnoletti JP
    Ann Surg Oncol; 2007 Jul; 14(7):2150-8. PubMed ID: 17453292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.
    Itakura J; Ishiwata T; Friess H; Fujii H; Matsumoto Y; Büchler MW; Korc M
    Clin Cancer Res; 1997 Aug; 3(8):1309-16. PubMed ID: 9815813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCK-B receptor gene and response to cholecystokinin-tetrapeptide in healthy volunteers.
    Koszycki D; Prichard Z; Fiocco AJ; Shlik J; Kennedy JL; Bradwejn J
    Peptides; 2012 May; 35(1):9-13. PubMed ID: 22414867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.
    Mukhopadhyay A; Nikopoulos K; Maugeri A; de Brouwer AP; van Nouhuys CE; Boon CJ; Perveen R; Zegers HA; Wittebol-Post D; van den Biesen PR; van der Velde-Visser SD; Brunner HG; Black GC; Hoyng CB; Cremers FP
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3565-72. PubMed ID: 16877430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma.
    Chang VH; Chu PY; Peng SL; Mao TL; Shan YS; Hsu CF; Lin CY; Tsai KK; Yu WC; Ch'ang HJ
    Am J Pathol; 2012 Aug; 181(2):423-30. PubMed ID: 22688058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.